FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Fresh danger signs for Cox-2 inhibitors

Researchers at the American Heart Association's Dallas gathering have issued a new warning that Vioxx and Celebrex raise the risk of death among patients who have already survived a heart attack. Dr. Gunnar Gislason, a research fellow at Bispebjerg University Hospital in Copenhagen, said Cox-2 inhibitors should not be used by patients suffering heart disease.

- read this CNN report for more


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Vioxx   heart disease   cox 2 inhibitor   Celebrex